In a bid to strengthen its leadership position in the digestive antacid market in India, GlaxoSmithKline Consumer Healthcare has launched liquid and tablet versions of its Eno brand. So far, Eno has been available only in powder form. Eno's six-tablet pack will be available at Rs 8, while its 170-ml liquid bottle is priced at Rs 68.
‘Eno’ is company’s third-largest brand, after Horlicks and Boost, which together accounted for 80% of the company's turnover of Rs 940 crore in 2012-13. The digestive antacid market in India is estimated at Rs 800 crore, of which powders constitute about 45%.
GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
| Company Name | CMP |
|---|---|
| Varun Beverages | 484.95 |
| Nestle | 1410.05 |
| Britannia Inds | 5670.35 |
| LT Foods | 417.80 |
| Hatsun Agro Product | 1009.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: